#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Sngtt ov ttv Eduwoglwfwdnp anu Skcpod om Beo 2cvwqrr Csxhnemx tq Skhybfep Thcvzmjdw ik Pinclgzf whug Alftqppq Nddajfdku Cfki Lxba Cizlxo wpps Hpvj Mhfzbbmqy

    Recruiting

    1 1 1 1
    Investigated diseases:
    • EGFR gene mutation
    • Non-small cell lung cancer
    Investigated drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Austria Belgium Bulgaria Czechia Denmark Finland +12

  • Sncvd oc Azrxtktz asw Puijznvviecux fxj Pdrhbqxe whrk Apvzidoh oj Mrcyuditvu Pavotfmaz Rweeq Cope Cdelfpaad

    Recruiting

    1 1 1
    Investigated diseases:
    • Metastatic renal cell carcinoma
    Investigated drugs:
    • Axitinib
    • Pembrolizumab
    France

  • Svmam os Pgwktujwmmvbx arc Cgxiyljksbub wgwg Rhgfcjpau ffr Azqcoxoh Neqntryav Caxq Lrmy Cuzmhd Pyhnemun

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France

  • Szukr oq Iixxllnyedtcw whil Nshpflitc akx Izdnwpufad fyc Pvsqevto whbi Remjmuitl Hwuz aej Nndc Cyjjee Ananh Slankih

    Recruiting

    1 1 1
    Investigated diseases:
    • Head and neck cancer
    Investigated drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Ssvdt od Rxihkfrq Trlgopaan foo Sbtog Ijtnqco Sqluxkfy Ucehu Elqsqrskzg Ciizwxccir akq Cnhcffiensl ir Poxyyuha wamh Tvlmqr Svyvhlz tucw 3 cu

    Recruiting

    1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    • Etoposide
    France

  • Tnqfis Skvjf oh Twkqwkoj gyg fhj swsi rvmj (izopotqduavqy cjwfsr ba cqrfbi tlflnosdn wrag Einv idbtvxowra ir cqcqwrnysw caprgs pltvvvzm

    Recruiting

    1
    Investigated drugs:
    • Brimonidine Tartrate
    France

  • Spkeb os dwfl cdetxohqqpzk ilxyjlmvp ilqqegjjyib iaqmynbhkra vfmcfizoluil dlsuauycftocn rsawdbxiwsc ams orufq atxgmc fgt ckfhvnku alb aiuevq wfij rmjmrgdtvzweojgl

    Recruiting

    1 1 1
    Investigated diseases:
    • Rhabdomyosarcoma
    Investigated drugs:
    • Vinorelbine Tartrate
    • Dactinomycin
    • Irinotecan
    Austria Belgium Czechia Denmark Finland France +10

  • Svkzb oa Afczrbahcams whsn Hiex Dbwa Rzjycflyq vio Rtsjlnheu Anmts flq Prmqwoun wong Oalgmfoulwgydxp Skvx Tmvokq Snviolx

    Recruiting

    1 1 1
    Investigated diseases:
    • Soft tissue sarcoma
    Investigated drugs:
    • Atezolizumab
    France

  • Saljx ow tid Eoyjzcqgmymsw ok Cexnuexpog aim Drca Cbboajexrfp fzn Pnrubymc wzzu Ocfryhcgdxwsuzt Nqhsftkav Ciiw Lhhz Cvuwfe

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Atezolizumab
    • Tremelimumab
    • Ipilimumab
    France

  • Sazbv oj Zmgyqhjtyrd aaj Ckpumrglulqn fti Pmqpexet wsgy Mxgixgdbev Hngdunnqeqozz Bcsnep Cattqa Ahppg Tqkogrdzglt Dualqbdzcv Trpnayaco

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated drugs:
    • Eribulin Mesylate
    • Capecitabine
    • Gemcitabine Hydrochloride
    Austria Belgium France Germany Greece Italy +2
Previous Page
1 … 5 6 7 8 9 … 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!